Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic transplantation and the risk for transmission of genetic disease: the heritable cancer disorders.

Stem cells and development - 1 Apr 2007

McMilin Kenneth D, Dasgupta Susmita

Abstract excerpt

With the development of new approaches to transplantation therapy, such as those building upon the potential found in stem cells, it is vital to pursue a clear understanding of transplantation risks. Allogeneic transplantation presents risk for the transmission of disease of various types, including genetic disease. Predisposition to develop cancer is a feature of numerous genetic disorders, and it may be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Genetic Diseases, Inborn
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Penetrance

Share to Risk Factors

Share to Transplantation, Homologous

Source

Identifiers

PMID: 17521232
DOI: 10.1089/scd.2006.0080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic transplantation and the risk for transmission of genetic disease: the heritable cancer disorders.PMID 17521232Read ↗

Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy.Semantic proximity Read ↗

Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Genetic variation and hematopoietic stem cell transplantation: expansion of the paradigm.Semantic proximity Read ↗

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignanciesSemantic proximity Read ↗

Transplant genetics and genomics.Semantic proximity Read ↗

Genetic susceptibility to iatrogenic malignancy.Semantic proximity Read ↗

Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.Semantic proximity Read ↗

Management of the risks for inherited disease in donor-conceived offspring.Semantic proximity Read ↗

Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disordersSemantic proximity Read ↗

Who am I? Optimal Tissue for Germline Genetic Testing Post-Stem Cell TransplantationSemantic proximity Read ↗

Fanconi's Anemia, transplantation, and cancerSemantic proximity Read ↗

Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some AnswersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.